Graham v. Boehringer Ingelheim Pharmaceuticals, Inc.

967 A.2d 112, 291 Conn. 903
CourtSupreme Court of Connecticut
DecidedMarch 11, 2009
StatusPublished

This text of 967 A.2d 112 (Graham v. Boehringer Ingelheim Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Graham v. Boehringer Ingelheim Pharmaceuticals, Inc., 967 A.2d 112, 291 Conn. 903 (Colo. 2009).

Opinion

967 A.2d 112 (2009)
291 Conn. 903

Edward GRAHAM
v.
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., et al.

Supreme Court of Connecticut.

Decided March 11, 2009.

John R. Williams, New Haven, in support of the petition.

Margaret J. Strange and Holly L. Cini, Hartford, in opposition.

The plaintiff's petition for certification for appeal from the Appellate Court (AC 30575) is denied.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
967 A.2d 112, 291 Conn. 903, Counsel Stack Legal Research, https://law.counselstack.com/opinion/graham-v-boehringer-ingelheim-pharmaceuticals-inc-conn-2009.